Market closed
Boston Scientific/$BSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Boston Scientific
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Ticker
$BSX
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
53,000
Website
BSX Metrics
BasicAdvanced
$141B
76.42
$1.25
0.81
-
Price and volume
Market cap
$141B
Beta
0.81
52-week high
$107.17
52-week low
$65.52
Average daily volume
7.8M
Financial strength
Current ratio
1.081
Quick ratio
0.464
Long term debt to equity
42.581
Total debt to equity
51.029
Interest coverage (TTM)
10.66%
Management effectiveness
Return on assets (TTM)
5.03%
Return on equity (TTM)
8.89%
Valuation
Price to earnings (TTM)
76.416
Price to revenue (TTM)
8.393
Price to book
6.47
Price to tangible book (TTM)
-70.32
Price to free cash flow (TTM)
52.742
Growth
Revenue change (TTM)
17.61%
Earnings per share change (TTM)
16.82%
3-year revenue growth (CAGR)
12.10%
3-year earnings per share growth (CAGR)
21.90%
What the Analysts think about BSX
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Boston Scientific stock.
BSX Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
BSX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
BSX News
AllArticlesVideos
Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)
Seeking Alpha·1 week ago
Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System
GlobeNewsWire·2 weeks ago
What's Behind The 130% Rise In BSX Stock?
Forbes·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Boston Scientific stock?
Boston Scientific (BSX) has a market cap of $141B as of March 13, 2025.
What is the P/E ratio for Boston Scientific stock?
The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 76.42 as of March 13, 2025.
Does Boston Scientific stock pay dividends?
No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of March 13, 2025.
When is the next Boston Scientific dividend payment date?
Boston Scientific (BSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Boston Scientific?
Boston Scientific (BSX) has a beta rating of 0.81. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.